Business Context and Reporting Period
This Form 8-K is a Current Report filed by Tharimmune, Inc. (not Canton Strategic Holdings, Inc.) on January 26, 2026. The registrant is a Delaware corporation with its principal executive offices in Red Bank, NJ, and its common stock trades on The Nasdaq Stock Market under the symbol THAR. The company is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate event rather than financial performance data.
Material Changes
Under Item 8.01 (Other Events), the Company announced its role as a Super Validator on the Canton network. This represents a strategic operational development rather than a change in historical financial results.
Guidance, Outlook, and Risks
The filing incorporates a press release (Exhibit 99.1) detailing the Super Validator announcement. No specific financial guidance, forward-looking projections, risk factors, or contingencies are explicitly detailed within the body of this 8-K text.
Investor Verification Checklist
- Verify the exact responsibilities and revenue implications of the "Super Validator" role on the Canton network by reviewing the attached press release (Exhibit 99.1).
- Confirm the company name discrepancy: The filing is for Tharimmune, Inc., despite the request metadata referencing "Canton Strategic Holdings, Inc."
- Check for subsequent filings to determine if this role results in material financial contracts or revenue recognition.